




| Calcium 1,000 mg/d (elemental from calcium carbonate) and vitamin D3 400 IU (10 ug) reduced risk. [Aging Clin Exp Res. 2005 Apr;17(2):125-32. 43407, 43537/43598 (9/2005)] Summary Interview |
| Calcium citrate 1000 mg/d (elemental ) in divided doses with meals and vitamin D2 1000 iu/d with the evening meal. [Arch Intern Med, 2008;168(1):103-8. 46001 (6/2008)] Summary Interview |
| Caffeine withdrawal symptoms in a.m.. [The Lancet, 1997;349:279-281. 27049 (1997)] Summary Interview |
| Diet - eliminate caffeine, sucrose and eat a higher protein and lower carbohydrate diet x 2 weeks. [The Nutrition Report, March 1991;9(3):17,24. 12081 (1996)] Summary Interview |
| Vitamin B12 normal ranges should be 600 to 2000 pg/ml. Below 550 to 600 pg/ml deficiencies start to appear in the CSF. Humans are born with serum levels of about 2000 pg/ml, which decline gradually throughout life. [Medical Hypotheses, 1991;34:131-140. 28725 (1998)] Summary Interview |
Fatigue - vitamin c, intravenous - 49041 Vitamin C as ascorbic acid alone at 10 grams given over 30 minutes in 100 cc of normal saline improved fatigue in fatigued office workers without side effects. Fatigue symptoms improved within 2 hours and lasted for a day. Vitamin C reduced oxidative stress and increased blood levels of vitamin C. No other nutrients were give with the vitamin C. [ Nutr J. 2012 Jan 20; 11(1):7. 49041 (3/2012)] Summary Interview PubMed |
Fibrinogen (lowering) - Alcohol Alcohol (moderate); cigarette smoking cessation (significantly reduces); exercise; garlic; omega-3 fatty acid rich diets; vegetarian diet; weight loss. [Arterio, Thromb, Vasc Biol, September, 1995;15(9):1263-1268. 24063 (1996)] Summary Interview |
Fibrinogen (lowering) - Cardiovascular risk factor Cardiovascular risk factor. [Arterio, Thromb, Vasc Biol, September, 1995;15(9): 1263-1268. 24063 (1996)] Summary Interview |
Fibrinogen (lowering) - Niacin Niacin: Day 1 0.25 gm after lunch, 0.5 gm after dinner and 0.5 gm at night. Day 2 0.25 gm after breakfast, 0.5 gm after lunch, 0.5 gm after dinner and 1gm at night. Day 3 0.25 gm after breakfast, 0.5 gm after lunch, 1gm after dinner and 1gm at night. Day 4 1gm four times daily, taken immediately after the meals and at bedtime. Niacin therapy: Fibrinogen is lowered by 15%; raises HDL-C by 20- 40%; HDL2-C, the large HDL particle is raised by up to 100%; a negligible effect on smaller HDL3; LDL-C is lowered by 15-30%; small, dense LDL particles are significantly lowered; triglycerides are lowered by 15-40%; and Lp(a) decreases10-40%. [J Intern Med. 2005 Aug;258(2):94-114. 43553 (01/2005)] Summary Interview |
Fibrinogen (lowering) - omega-3 fatty acids, epa, dha - 48958 Omega-3 fatty acid (EPA and DHA) serum levels are inversely associated with fibrinogen levels. Two fish servings per week approximately 1 gram combined EPA and DHA per day. [Eur J Clin Nutr, 2011 Sep 7; [Epub ahead of print]. 48958 (12/2011)] Summary Interview PubMed |
| Pycnogenol™ 50 mg per tablet taken twice a day, after breakfast and after dinner. [Redox Rep, 2008; 13(6): 271-6. 46883 (3/2009)] Summary Interview PubMed |
Fibrocystic Breast Disease - omega-3 fatty acid - 46920 Omega-3 fatty acid eicosapentaenoic acid (EPA) elevated in RBC is protective. Am J Clin Nutr, 2009; 89(1): 265-76. 46920 (4/2009) Summary Interview PubMed |
Fibroids (uterine) - Enterolignans Higher urine levels of enterolignans (lignans) reduce risk of fibroids. [Am J Clin Nutr, 2006 Sep;84(3):587-93. 45305 (2/2007)] Summary Interview |
Fibromyalgia - coenzyme q10 - 48643 Coenzyme Q10 300 mg/d (soft gel capsules) in three divided doses with meals. [Mitochondrion, 2011 April 7; [Epub ahead of print]. 48643 (5/2011)] Summary Interview PubMed |
Fibromyalgia - d-ribose - 41201 / 42747 D-ribose at 5 gms t.i.d. with or without meals for approximately 3 weeks (loading dose) then 5 gm b.i.d. for up to six weeks (can stop if no benefit). [Pharmacotherapy, 2004;24(11):1646-1648. 41201/42747 (02/2005)] Summary Interview |
Fibromyalgia - d-ribose - 44986 / 45599 D-ribose at 5 gms t.i.d. with or without meals for approximately 3 weeks (loading dose) then 5 gm b.i.d. for up to six weeks (can stop if no benefit). [J Altern Complement Med, 2006 Nov;12(9):857-62. 44986/45599 (4/2007)] Summary Interview PubMed |
Fibrosis (submucous) - lycopene - 49480 Lycopene (soft gel LycoredTM) at 4 mg twice a day with meals ameliorated the signs and symptoms of oral submucous fibrosis (pre-malignant condition) and improved maximal mouth opening percentage with no side effects. [Indian J Dent Res, 2012 July; 23(4): [Epub ahead of print]. 49480 (2/2013)] Summary Interview PubMed |
Fibrosis - alpha lipoic acid - 48558 Alpha lipoic acid 100 mg after meals once daily for 3 months in conjunction with intralesional steroids and hyaluronidase.[J Cancer Res Ther, 2010 Oct-Dec; 6(4): 508-10. 48558 (04/2011)] Summary Interview PubMed |
| Folic acid fortification may correct nucleotide polymorphisms (SNPs) that may reduce the risk to cardiovascular disease, cancer and birth defects. [BMJ USA, March 2004;4:127-131. 41556 (2004)] Summary Interview |
Folic acid - Fortification - 2 Folic acid fortification with pteroylmonoglutamic acid (PGA) is not the natural form of the folic acid but is cheap and stable. 5-methyl-H4 folate (5-MTHF) is the major transport form of the vitamin outside the cell. A single dose of 400 mcg (or less) of PGA is converted efficiently into 5-methyl-H4 folate during absorption. The absorption and biotransformation process is saturated at this 400 mcg dose, and anything higher intake will lead to unmodified PGA appearing in the blood which have unknown toxicity. [BMJ USA, March 2004;4:127-131. 41556 (2004)] Summary Interview |
Fracture (hip) - calcium - vitamin d - 47310 Calcium 500 mg and vitamin D 400 IU once or twice daily improved post-fracture (hip) survival. [Drugs Aging, 2009;26(5):409-21. 47310 (9/2009)] Summary Interview PubMed |
Fracture (hip) - calcium - vitamin d - 47310 Calcium 500 mg and vitamin D 400 IU once or twice daily improved post-fracture (hip) survival. [Drugs Aging, 2009;26(5):409-21. 47310 (9/2009)] Summary Interview PubMed |
Fracture (hip) - risk factors - 22016 Risk factors - bisphosphonates, caffeine, estrogen therapy, exercise lack, frailty, hip fracture previously, medications (sedatives, hypnotics), visual impairment. [NEJM, March 25, 1995;12:767-773. 22016 (1996)] Summary Interview PubMed |
Fracture (hip) - sunlight exposure - 43486 Sunlight exposure (3615 minutes/year or 10 minutes/d) in hospitalized Alzheimer’s patients over 1 year reduced fractures and increased vitamin D levels 2.2 fold. [J Bone Mineral Res, 2005;20(8):1327-1333. 43486 (8/2005)] Summary Interview PubMed |
Fracture (hip) - vitamin d2 - 43662 / 43704 Vitamin D2 (ergocalciferol) 1000 IU/d, vitamin K2 (menatetrenone) 45 mg/d and calcium 600 mg/d (reduced incidence). [Bone. 2005 Jan;36(1):61-8. Epub 2004 Nov 24. 43662/43704 (9/2005)] Summary Interview PubMed |
Fragile X Syndrome (FXS) - Acetyl-L-carnitine Acetyl-L-carnitine 20-50 mg/kg/d b.i.d. in granular form dissolved in water or other liquids with or without meals. [Am J Med Genet A, 2008; 146(7): 803-12. 46191 (7/2008)] Summary Interview |
| Powered by Sigsiu.NET | ![]() |